{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T23:33:48Z","timestamp":1777937628776,"version":"3.51.4"},"reference-count":52,"publisher":"Medical Association of Nippon Medical School","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Nippon Med Sch"],"published-print":{"date-parts":[[2026,4,20]]},"DOI":"10.1272\/jnms.jnms.2026_93-206","type":"journal-article","created":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T22:15:19Z","timestamp":1777587319000},"page":"122-134","source":"Crossref","is-referenced-by-count":0,"title":["Placenta-Specific miRNA &lt;i&gt;miR-515-3p&lt;\/i&gt; Suppresses &lt;i&gt;HMGB3&lt;\/i&gt; Expression in the Breast Cancer Cell Line MCF-7"],"prefix":"10.1272","volume":"93","author":[{"given":"Ai","family":"Sato","sequence":"first","affiliation":[{"name":"Department of Molecular Medicine and Anatomy, Nippon Medical School"},{"name":"Department of Breast Surgery and Oncology, Nippon Medical School"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroyuki","family":"Takei","sequence":"additional","affiliation":[{"name":"Department of Breast Surgery and Oncology, Nippon Medical School"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Syunya","family":"Noguchi","sequence":"additional","affiliation":[{"name":"Department of Molecular Medicine and Anatomy, Nippon Medical School"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toshihiro","family":"Takizawa","sequence":"additional","affiliation":[{"name":"Department of Molecular Medicine and Anatomy, Nippon Medical School"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"21","reference":[{"key":"1","unstructured":"1. National Cancer Center Japan. [Cancer statistics by type: Breast] [Internet]. 2016 Apr 18. [cited 2025 May 27]. Available from: https:\/\/ganjoho.jp\/reg_stat\/statistics\/stat\/cancer\/14_breast.html. Japanese."},{"key":"2","unstructured":"2. Han SN, Van Calsteren K, Heyns L, Mhallem Gziri M, Amant F. Breast cancer during pregnancy: a literature review. Minerva Ginecol. 2010 Dec;62 (6):585-97."},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Chikhirzhina E, Tsimokha A, Tomilin AN, Polyanichko A. Structure and functions of HMGB3 protein. Int J Mol Sci. 2024 Jul 12;25 (14):7656.","DOI":"10.3390\/ijms25147656"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Wen B, Wei YT, Zhao K. The role of high mobility group protein B3 (HMGB3) in tumor proliferation and drug resistance. Mol Cell Biochem. 2021 Apr;476 (4):1729-39.","DOI":"10.1007\/s11010-020-04015-y"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Niu L, Yang W, Duan L, et al. Biological functions and theranostic potential of HMGB family members in human cancers. Ther Adv Med Oncol. 2020 Nov 10;12:1758835920970850.","DOI":"10.1177\/1758835920970850"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Gu J, Xu T, Huang QH, Zhang CM, Chen HY. HMGB3 silence inhibits breast cancer cell proliferation and tumor growth by interacting with hypoxia-inducible factor 1\u03b1. Cancer Manag Res. 2019 May 31;11:5075-89.","DOI":"10.2147\/CMAR.S204357"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Sharma P, Yadav P, Sundaram S, Venkatraman G, Bera AK, Karunagaran D. HMGB3 inhibition by miR-142-3p\/sh-RNA modulates autophagy and induces apoptosis via ROS accumulation and mitochondrial dysfunction and reduces the tumorigenic potential of human breast cancer cells. Life Sci. 2022 Sep 1;304:120727.","DOI":"10.1016\/j.lfs.2022.120727"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Elgamal OA, Park JK, Gusev Y, et al. Tumor suppressive function of mir-205 in breast cancer is linked to HMGB3 regulation. PLoS One. 2013 Oct 2;8 (10):e76402.","DOI":"10.1371\/journal.pone.0076402"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Zhou X, Zhang Q, Liang G, Liang X, Luo B. Overexpression of HMGB3 and its prognostic value in breast cancer. Front Oncol. 2022 Dec 22;12:1048921.","DOI":"10.3389\/fonc.2022.1048921"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Bartel DP. MicroRNAs: target recognition and regulatory functions. Cell. 2009 Jan 23;136 (2):215-33.","DOI":"10.1016\/j.cell.2009.01.002"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Esteller M. Non-coding RNAs in human disease. Nat Rev Genet. 2011 Nov 18;12 (12):861-74.","DOI":"10.1038\/nrg3074"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Croce CM. Causes and consequences of microRNA dysregulation in cancer. Nat Rev Genet. 2009 Oct;10 (10):704-14.","DOI":"10.1038\/nrg2634"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Landgraf P, Rusu M, Sheridan R, et al. A mammalian microRNA expression atlas based on small RNA library sequencing. Cell. 2007 Jun 29;129 (7):1401-14.","DOI":"10.1016\/j.cell.2007.04.040"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Rishik S, Hirsch P, Grandke F, Fehlmann T, Keller A. miRNATissueAtlas 2025: an update to the uniformly processed and annotated human and mouse non-coding RNA tissue atlas. Nucleic Acids Res. 2025 Jan 6;53 (D1):D129-37.","DOI":"10.1093\/nar\/gkae1036"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Safa A, Bahroudi Z, Shoorei H, et al. miR-1: a comprehensive review of its role in normal development and diverse disorders. Biomed Pharmacother. 2020 Dec;132:110903.","DOI":"10.1016\/j.biopha.2020.110903"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Mouillet JF, Ouyang Y, Coyne CB, Sadovsky Y. MicroRNAs in placental health and disease. Am J Obstet Gynecol. 2015 Oct;213 (4 Suppl):S163-72.","DOI":"10.1016\/j.ajog.2015.05.057"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Dumont TMF, Mouillet JF, Bayer A, et al. The expression level of C19MC miRNAs in early pregnancy and in response to viral infection. Placenta. 2017 May;53:23-9.","DOI":"10.1016\/j.placenta.2017.03.011"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Miura K, Miura S, Yamasaki K, et al. Identification of pregnancy-associated microRNAs in maternal plasma. Clin Chem. 2010 Nov;56 (11):1767-71.","DOI":"10.1373\/clinchem.2010.147660"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Luo SS, Ishibashi O, Ishikawa G, et al. Human villous trophoblasts express and secrete placenta-specific microRNAs into maternal circulation via exosomes. Biol Reprod. 2009 Oct;81 (4):717-29.","DOI":"10.1095\/biolreprod.108.075481"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. Noguchi S, Tozawa S, Sakurai T, et al. BeWo exomeres are enriched for bioactive extracellular placenta-specific C19MC miRNAs. J Reprod Immunol. 2024 Feb;161:104187.","DOI":"10.1016\/j.jri.2023.104187"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21. Ogoyama M, Ohkuchi A, Takahashi H, Zhao D, Matsubara S, Takizawa T. LncRNA H19-derived miR-675-5p accelerates the invasion of extravillous trophoblast cells by inhibiting GATA2 and subsequently activating matrix metalloproteinases. Int J Mol Sci. 2021 Jan 27;22 (3):1237.","DOI":"10.3390\/ijms22031237"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22. Kambe S, Yoshitake H, Yuge K, et al. Human exosomal placenta-associated miR-517a-3p modulates the expression of PRKG1 mRNA in Jurkat cells. Biol Reprod. 2014 Nov;91 (5):129.","DOI":"10.1095\/biolreprod.114.121616"},{"key":"23","unstructured":"23. University of Manchester. Homo sapiens miRNAs [Internet]. Manchester (GB): University of Manchester; 2006. [cited 2021 Oct 23]. Available from: https:\/\/www.mirbase.org\/browse\/results\/?organism=hsa"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24. Agarwal V, Bell GW, Nam JW, Bartel DP. Predicting effective microRNA target sites in mammalian mRNAs. Elife [Internet]. 2015 Aug 12;4:e05005. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/26267216","DOI":"10.7554\/eLife.05005"},{"key":"25","unstructured":"25. Whitehead Institute for Biomedical Research. Search for predicted microRNA targets in mammals [Internet]. Cambridge (GB): Whitehead Institute for Biomedical Research; 2006. [cited 2021 Oct 23]. Available from: https:\/\/www.targetscan.org\/vert_72"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26. Vejnar CE, Zdobnov EM. MiRmap: comprehensive prediction of microRNA target repression strength. Nucleic Acids Res [Internet]. 2012 Dec;40 (22):11673-83. Available from: https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/23034802","DOI":"10.1093\/nar\/gks901"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27. Vejnar CE, Zdobnov EM. miRmap: comprehensive prediction of microRNA target repression strength. Nucleic Acids Res [Internet]. 2012 Dec 1 [cited 2021 Oct 23]; 40 (22):11673-83. Available from: https:\/\/academic.oup.com\/nar\/article\/40\/22\/11673\/1146893?login=true","DOI":"10.1093\/nar\/gks901"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28. Chen Y, Wang X. miRDB: an online database for prediction of functional microRNA targets. Nucleic Acids Res [Internet]. 2020 Jan 8;48 (D1):D127-31. Available from: https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/31504780","DOI":"10.1093\/nar\/gkz757"},{"key":"29","unstructured":"29. miRDB Target Search [Internet]. [place unknown]: miRDB;. [cited 2021 Oct 23]. Available from: https:\/\/mirdb.org\/index.html"},{"key":"30","doi-asserted-by":"crossref","unstructured":"30. Sticht C, De La Torre C, Parveen A, Gretz N. miRWalk: an online resource for prediction of microRNA binding sites. PLoS One [Internet]. 2018 Oct 18;13 (10):e0206239. Available from: https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/30335862","DOI":"10.1371\/journal.pone.0206239"},{"key":"31","unstructured":"31. miRWalk Team. Search for a single gene or miRNA [Internet]. Mannheim: Medical Faculty Mannheim (DE), Heidelberg University; 2018. [cited 2021 Oct 23]. Available from: http:\/\/mirwalk.umm.uni-heidelberg.de"},{"key":"32","doi-asserted-by":"crossref","unstructured":"32. Panwar B, Omenn GS, Guan Y. miRmine: a database of human miRNA expression profiles. Bioinformatics [Internet]. 2017 May 15;33 (10):1554-60. Available from: https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/28108447","DOI":"10.1093\/bioinformatics\/btx019"},{"key":"33","unstructured":"33. University of Michigan. miRmine - Human miRNA Expression Database [Internet]. Ann Arbor (MI): University of Michigan; 2017. [cited 2021 Oct 18]. Available from: http:\/\/bioconductor.riken.jp\/packages\/3.16\/bioc\/html\/miRmine.html"},{"key":"34","doi-asserted-by":"crossref","unstructured":"34. Zhang Z, Chang Y, Zhang J, et al. HMGB3 promotes growth and migration in colorectal cancer by regulating WNT\/\u03b2-catenin pathway. PLoS One. 2017 Jul 5;12 (7):e0179741.","DOI":"10.1371\/journal.pone.0179741"},{"key":"35","doi-asserted-by":"crossref","unstructured":"35. Zhuang S, Yu X, Lu M, Li Y, Ding N, Ding Y. High mobility group box 3 promotes cervical cancer proliferation by regulating Wnt\/\u03b2-catenin pathway. J Gynecol Oncol. 2020 Nov;31 (6):e91.","DOI":"10.3802\/jgo.2020.31.e91"},{"key":"36","doi-asserted-by":"crossref","unstructured":"36. Gong W, Guo Y, Yuan H, et al. HMGB3 is a potential therapeutic target by affecting the migration and proliferation of colorectal cancer. Front Cell Dev Biol. 2022 May 31;10:891482.","DOI":"10.3389\/fcell.2022.891482"},{"key":"37","doi-asserted-by":"crossref","unstructured":"37. Ji Y, Lv J, Sun D, Huang Y. Therapeutic strategies targeting Wnt\/\u03b2-catenin signaling for colorectal cancer (Review). Int J Mol Med. 2022 Jan;49 (1):1.","DOI":"10.3892\/ijmm.2021.5056"},{"key":"38","doi-asserted-by":"crossref","unstructured":"38. Butti R, Das S, Gunasekaran VP, Yadav AS, Kumar D, Kundu GC. Receptor tyrosine kinases (RTKs) in breast cancer: signaling, therapeutic implications and challenges. Mol Cancer. 2018 Feb 19;17 (1):34.","DOI":"10.1186\/s12943-018-0797-x"},{"key":"39","doi-asserted-by":"crossref","unstructured":"39. Luo LY, Hahn WC. Oncogenic signaling adaptor proteins. J Genet Genomics. 2015 Oct 20;42 (10):521-9.","DOI":"10.1016\/j.jgg.2015.09.001"},{"key":"40","doi-asserted-by":"crossref","unstructured":"40. Regad T. Targeting RTK signaling pathways in cancer. Cancers (Basel). 2015 Sep 3;7 (3):1758-84.","DOI":"10.3390\/cancers7030860"},{"key":"41","doi-asserted-by":"crossref","unstructured":"41. Li X, Wu Y, Liu A, Tang X. MiR-27b is epigenetically downregulated in tamoxifen resistant breast cancer cells due to promoter methylation and regulates tamoxifen sensitivity by targeting HMGB3. Biochem Biophys Res Commun. 2016 Sep 2;477 (4):768-73.","DOI":"10.1016\/j.bbrc.2016.06.133"},{"key":"42","unstructured":"42. Aljohani AI, Alsaeed SA, Toss MS, Raafat SA, Green AR, Rakha EA. The expression of high mobility group protein 3 (HMGB3) in breast cancer with emphasis on its role in lymphovascular invasion. Am J Cancer Res. 2023 Nov 15;13 (11):5334-51."},{"key":"43","doi-asserted-by":"crossref","unstructured":"43. Sharma MP, Shukla S, Misra G. Recent advances in breast cancer cell line research. Int J Cancer. 2024 May 15;154 (10):1683-93.","DOI":"10.1002\/ijc.34849"},{"key":"44","doi-asserted-by":"crossref","unstructured":"44. Dai X, Cheng H, Bai Z, Li J. Breast cancer cell line classification and its relevance with breast tumor subtyping. J Cancer. 2017 Sep 12;8 (16):3131-41.","DOI":"10.7150\/jca.18457"},{"key":"45","doi-asserted-by":"crossref","unstructured":"45. Xu J, Chen Y, Olopade OI. MYC and breast cancer. Genes Cancer. 2010 Jun;1 (6):629-40.","DOI":"10.1177\/1947601910378691"},{"key":"46","doi-asserted-by":"publisher","unstructured":"46. Fallah Y, Brundage J, Allegakoen P, Shajahan-Haq AN. MYC-driven pathways in breast cancer subtypes. Biomolecules. 2017 Jul 11;7 (3):53.","DOI":"10.3390\/biom7030053"},{"key":"47","doi-asserted-by":"crossref","unstructured":"47. Xu J, Chen Y, Huo D, et al. \u03b2-catenin regulates c-Myc and CDKN1A expression in breast cancer cells. Mol Carcinog. 2016 May;55 (5):431-9.","DOI":"10.1002\/mc.22292"},{"key":"48","doi-asserted-by":"crossref","unstructured":"48. Liu H, Radisky DC, Yang D, et al. MYC suppresses cancer metastasis by direct transcriptional silencing of \u03b1v and \u03b23 integrin subunits. Nat Cell Biol. 2012 May 13;14 (6):567-74.","DOI":"10.1038\/ncb2491"},{"key":"49","doi-asserted-by":"crossref","unstructured":"49. Ma X, Huang J, Tian Y, et al. Myc suppresses tumor invasion and cell migration by inhibiting JNK signaling. Oncogene. 2017 Jun 1;36 (22):3159-67.","DOI":"10.1038\/onc.2016.463"},{"key":"50","doi-asserted-by":"crossref","unstructured":"50. Cappellen D, Schlange T, Bauer M, Maurer F, Hynes NE. Novel c-MYC target genes mediate differential effects on cell proliferation and migration. EMBO Rep. 2007 Jan;8 (1):70-6.","DOI":"10.1038\/sj.embor.7400849"},{"key":"51","doi-asserted-by":"crossref","unstructured":"51. Schlam I, Swain SM. HER2-positive breast cancer and tyrosine kinase inhibitors: the time is now. NPJ Breast Cancer. 2021 May 20;7 (1):56.","DOI":"10.1038\/s41523-021-00265-1"},{"key":"52","unstructured":"52. Japanese Breast Cancer Society. [Breast Cancer Treatment Guidelines 2022 Edition] [Internet]. Tokyo: Japanese Breast Cancer Society; 2022 Nov 15. [BQ (Background Question) 18: Is breast cancer during pregnancy or lactation associated with poor prognosis?];. [cited 2025 May 27]. Available from: https:\/\/jbcs.xsrv.jp\/guideline\/2022\/e_index\/bq18. Japanese."}],"container-title":["Journal of Nippon Medical School"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jnms\/93\/2\/93_JNMS.2026_93-206\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,2]],"date-time":"2026-05-02T04:11:32Z","timestamp":1777695092000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jnms\/93\/2\/93_JNMS.2026_93-206\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,20]]},"references-count":52,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1272\/jnms.jnms.2026_93-206","relation":{},"ISSN":["1345-4676","1347-3409"],"issn-type":[{"value":"1345-4676","type":"print"},{"value":"1347-3409","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,20]]},"article-number":"JNMS.2026_93-206"}}